Diabetes complications

Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care

Diabetes Technol TherPublished Retrospective cohort study

Authors' conclusion

In this real-world screening-based cohort of adults with T1D, mild NPDR demonstrated a highly dynamic course, with more than half of patients experiencing regression over 5 years. Overall glycemic control, reflected by HbA1c, was the primary determinant of regression. CGM-derived metrics did not provide additional predictive value beyond HbA1c in this setting.

Study context

Population
Adults with T1D and mild non-proliferative diabetic retinopathy (NPDR) identified by digital fundus photography within a screening program, 2018–2020; median age 39 years, median diabetes duration 21 years
Participants
113 adults
Outcome
Retinopathy outcome: regression (absence of retinopathy), stability (persistent mild NPDR) or progression (moderate/severe NPDR and/or DME)
Follow-up
≈5 years
Methodological detailsscreening-based, real-world
  • Screening-based
  • Real-world

Main finding

As reported in the abstract

Evolution of mild NPDR

Regression

57.5%

Remained stable

31.0%

Progressed

11.5%

Observational data: associations, not effects.

Further findings

Factors associated with regression

Lower HbA1c at follow-up in participants with regression vs those without
Continuous glucose monitoring (CGM) metrics (incl. TIR, GMI) associated with regression in univariate analyses, but not independent of HbA1c due to strong collinearity
Multivariable analysis: lower HbA1c the only independent predictor of regression

Original publication

Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care. Diabetes Technol Ther. Published 21 August 2026. doi:10.1177/15209156261481005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.